Fragmented QRS, a strong predictor of mortality and major arrhythmic events in patients with nonischemic cardiomyopathy: A systematic review and meta‐analysis

• Published in: Health science reports Vol. 7; no. 2; pp. e1888 - n/a
• Main Authors: Zangiabadian, Moein, Sharifian Ardestani, Mohammad, Rezaee, Malihe, Saberi Sharbabaki, Elahe, Nikoohemmat, Mahdi, Eslami, Mohammad, Goudarzi, Kian, Sanjari, Mojgan, Namazi, Mohammad Hasan, Akbarzadeh, Mohammad Ali, Aletaha, Azadeh
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.02.2024; John Wiley and Sons Inc; Wiley
• Subjects: all‐cause mortality; Cardiology; Cardiomyopathy; Cardiovascular disease; Coronary vessels; Cross-sectional studies; Electrocardiography; fragmented QRS; Ischemia; major arrhythmic events; Meta-analysis; Mortality; nonischemic cardiomyopathy; Original Research; Statistical analysis; Systematic review; Vein & artery diseases; United States > US; China; all‐cause mortality; major arrhythmic events; meta‐analysis; nonischemic cardiomyopathy; systematic review; fragmented QRS
• ISSN: 2398-8835; 2398-8835
• DOI: 10.1002/hsr2.1888

Background and Aims Fragmented QRS (fQRS), which is associated with rhythm disturbances, can predispose the heart to fatal ventricular arrhythmias. Recently, accumulating studies indicates that fQRS is associated with poor prognosis in various types of cardiomyopathies. Therefore, we assessed the association between fQRS with all‐cause mortality and major arrhythmic events (MAEs) in patients with nonischemic cardiomyopathy, in this systematic review and meta‐analysis study. Methods We performed a comprehensive search in databases of PubMed/Medline, EMBASE, and Web of Science from the beginning to December 31, 2022. Published observational studies (cohorts, case–control, or analytical cross‐sectional studies) were included that report the prognostic value of fQRS in patients with different types of nonischemic cardiomyopathies for MAEs (sudden cardiac death, sudden cardiac arrest, sustained ventricular tachycardia [VT], ventricular fibrillation [VF], and appropriate shock) and all‐cause mortality. We pooled risk ratios (RRs) through raw data and adjusted hazard ratios (aHRs) using “Comprehensive Meta‐Analysis” software, Version 2.0. Results Nineteen cohort and three analytical cross‐sectional studies were included in this meta‐analysis involving a total of 4318 subjects with nonischemic cardiomyopathy (1279 with fQRS and 3039 without fQRS). FQRS was significantly associated with an increased risk of all‐cause mortality in patients with nonischemic cardiomyopathy (pooled RR: 1.920; 95% confidence interval [CI]: 1.388–2.656, p < 0.0001/pooled HR: 1.729; 95% CI: 1.327–2.251, p < 0.0001). Also, the risk of developing MAEs in the presence of fQRS was significantly increased (pooled RR: 2.041; 95% CI: 1.644–2.533, p < 0.0001/pooled HR: 3.626; 95% CI: 2.119–6.204, p < 0.0001). In the subgroup analysis, the strongest association between fQRS presence and increased MAEs was observed in patients with hypertrophic cardiomyopathy (HCM) (pooled RR: 3.44; 95% CI: 2.07–5.71, p < 0.0001/pooled HR: 3.21; 95% CI: 2.04–5.06, p < 0.0001). Conclusion Fragmented QRS could be a prognostic marker for all‐cause mortality and MAEs in patients with various types of nonischemic cardiomyopathies, particularly HCM.